Dr Reddys Laboratories Share Price Today - Live Blog for August 04, 2025

Dr Reddys Laboratories Ltd's share price has dropped by -0.22%, a development that warrants careful analysis. Presently trading at ₹1,222.00, investors are assessing whether this presents an opportunity or a risk.

Dr Reddys Laboratories Ltd observed a -0.15% decrease in its share price, a situation that merits attention. As of now, it's actively trading at ₹1,224.75. The stock has a PE ratio of 17.9200, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

Dr Reddys Laboratories Ltd's share price has fallen by -0.18%, presenting both challenges and opportunities for investors. As of now, it's trading at ₹1,226.65, and market participants are assessing the implications. The stock has a PE ratio of 17.9200, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

Dr Reddys Laboratories Ltd's share price rallied by 0.04%, reaching the current market price of ₹1,229.05. This surge is indicative of the stock's recent positive performance.

Increased investor interest has propelled Dr Reddys Laboratories Ltd's stock to a significant 0.07% gain, with the share price now at ₹1,229.00. Notably, the stock's PE ratio stands at 17.9200, and its Return on Equity (ROE) is 16.8559%.

Dr Reddys Laboratories Ltd share price surged by 0.02%. With its current market price standing at ₹1,228.20 per share, this stock is garnering increased attention from the investment community.

The stock of Dr Reddys Laboratories Ltd is facing a -0.01% decline and is currently trading at ₹1,228.85 per share. Investors are closely monitoring this situation for potential signs of a turnaround.

Dr Reddys Laboratories Ltd has had quite the run lately, experiencing a substantial 0.10% uptick in its share price. As a result, it's now actively trading at ₹1,229.00 per share, making it an attractive option for investors.

In recent times, Dr Reddys Laboratories Ltd witnessed a decline of -0.02% in its share price, and it currently trades at ₹1,228.05 per share. The stock has an ROE of 16.8559% and debt to equity ratio of 0.1394.

With a -0.09% decrease, Dr Reddys Laboratories Ltd's share price is now ₹1,228.00. Investors should examine the factors driving this decline. The stock's PE ratio is 17.9200, whereas the industry PE ratio stands at 34.4787.

Dr Reddys Laboratories Ltd observed a remarkable 0.26% surge in its share price and is presently trading at ₹1,229.05. The increased investor interest is driving this surge.

Dr Reddys Laboratories Ltd's shares experienced a 0.26% uptick, and they are currently valued at ₹1,229.05, making it an attractive choice for investors. The stock has a debt to equity ratio of 0.1394 and an ROE of 16.8559%.

With a -0.25% decrease, Dr Reddys Laboratories Ltd's share price is now ₹1,225.85. Investors should examine the factors driving this decline. The stock's PE ratio is 17.9200, whereas the industry PE ratio stands at 34.4787.

The share price of Dr Reddys Laboratories Ltd experienced a -0.25% slump and is currently trading at ₹1,225.85. While the stock maintains a PE ratio of 17.9200, the industry PE is 34.4787, raising questions about valuation.

Dr Reddys Laboratories Ltd's share price has dropped by -0.25%, a development that warrants careful analysis. Presently trading at ₹1,225.85, investors are assessing whether this presents an opportunity or a risk.

In the financial arena, Dr Reddys Laboratories Ltd's stock price has increased by 0.00%, with its current market value per share resting at ₹1,228.25. This development highlights the stock's appeal to investors.

Dr Reddys Laboratories Ltd shares saw a decrease of -0.17%, reaching a current market price of ₹1,228.20. Investors are evaluating the impact of this decline on the stock's overall performance and attractiveness.

Dr Reddys Laboratories Ltd's share price has fallen by -0.06%, a situation worth noting. At present, the stock is trading at ₹1,230.25. Investors might find this a moment to reassess their positions. The stock's current Price-to-Earnings (PE) ratio stands at 17.9200, while the industry PE ratio is 34.4787.

Dr Reddys Laboratories Ltd witnessed a notable 0.13% surge in its share price and is presently trading at ₹1,230.40, captivating the attention of market participants.

Dr Reddys Laboratories Ltd shares saw a -0.09% decrease, reaching a current market price of ₹1,229.00. Investors are keeping a close watch on this development, looking for potential signals of a turnaround. The stock has a PE ratio of 17.9200, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

Dr Reddys Laboratories Ltd's stock price surged by 0.15%, reaching the current market value of ₹1,230.15 per share. This surge is a testament to the stock's recent performance.

Dr Reddys Laboratories Ltd has had quite the run lately, experiencing a substantial 0.11% uptick in its share price. As a result, it's now actively trading at ₹1,227.50 per share, making it an attractive option for investors.

The share price of Dr Reddys Laboratories Ltd experienced an impressive 0.14% upswing and is currently trading at ₹1,226.00, indicating strong market sentiment.

Dr Reddys Laboratories Ltd shares saw a decrease of -0.18%, reaching a current market price of ₹1,224.30. Investors are evaluating the impact of this decline on the stock's overall performance and attractiveness.

Dr Reddys Laboratories Ltd shares saw a -0.04% decrease, reaching a current market price of ₹1,226.45. Investors are keeping a close watch on this development, looking for potential signals of a turnaround. The stock has a PE ratio of 17.9200, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

With a -0.01% decrease, Dr Reddys Laboratories Ltd's share price is now at ₹1,226.05. The stock is currently trading at a PE of 17.9200, while the industry PE is 34.4787, prompting investors to assess its value proposition.

The share price of Dr Reddys Laboratories Ltd soared by an impressive 0.07%, marking a substantial gain for investors. At present, this stock can be acquired at a current market price of ₹1,226.35 per share.

The stock of Dr Reddys Laboratories Ltd is facing a -0.33% decline and is currently trading at ₹1,225.55 per share. Investors are closely monitoring this situation for potential signs of a turnaround.

The share price of Dr Reddys Laboratories Ltd soared by an impressive 0.81%, marking a substantial gain for investors. At present, this stock can be acquired at a current market price of ₹1,230.50 per share.